Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

Zoliflodacin is an oral, single dose spiropyrimidinetrione that has activity against multidrug-resistant strains of Neisseria gonorrhoeae.

If evidence demonstrates equal effectiveness, providers favor CPAP, while patients lean toward tirzepatide.

HealthDay News — From 2013 to 2023, there was an increase in the proportion of US adults who were unaware of having hypertension, according to a research letter published online June 4 in JAMA ...

The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...

HealthDay News — For drivers with schizophrenia, better adherence to antipsychotic medications is associated with lower motor vehicle crash risk, according to a study published online June 9 in CMAJ, ...

For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone, ...

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Enlicitide decanoate is an investigational oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients.

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...